At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6,350 enrolled
Drug / intervention
HIV and HCV screeningother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Universal HIV Screening and Targeted HCV Screening in Emergency Department
Centre hospitalier de l'Université de Montréal (CHUM)·interventional·Posted Jul 23, 2018·Updated Feb 10, 2023
In Brief
A clinical study evaluating HIV and HCV screening for Hepatitis C and Hiv. Completed, enrolled 6,350 participants across 1 site.
Detailed Summary
Cross-sectional study of patients consulting in the emergency room of the Centre hospitalier de l'Université de Montréal (CHUM), to assess the implementation of an "opt-out" screening program for HIV and HCV and prospective follow-up for 3 months of positive cases.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatitis C, Hiv
CountriesCanada
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedJul 2018
Primary CompletionOct 2019
Study CompletionOct 2020
TodayJul 2026
First PostedJul 23, 2018
Enrollment StartJul 10, 2018
Primary CompletionOct 10, 2019
Study CompletionOct 10, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.9 years ago
Interventions
HIV and HCV screeningother
HIV test: ARCHITECT HIV Ag/Ab Combo, Abbott HCV test: ARCHITECT Anti-HCV, Abbott